论文部分内容阅读
Ｏｎｃａｓｐａｒ在美获准上市美国ＦＤＡ批准恩仲（Ｅｎｚｏｎ）公司研制的新药Ｏｎｃａｓｐａｒ上市，与化疗药物合用，治疗对天然Ｌ－天门冬酰胺酶过敏的急性成淋巴细胞白血病。Ｏｎｃａ；ｐａｒ于１９９１年１月在美国审批。１９９３年５月首次在俄罗斯批准用于治疗各...
Oncaspar Approved in US FDA Approves Oncaspar, a new drug developed by Enzon, for use in combination with chemotherapeutics to treat acute lymphoblastic leukemia that is allergic to natural L-asparaginase. Onca; par approved in the United States in January 1991. 1993 May for the first time in Russia approved for the treatment of ...